Literature DB >> 27443652

The Impact of Different Case Ascertainment Definitions on the Prevalence of Major Congenital Malformations and their Association with Asthma During Pregnancy.

Sherif Eltonsy1,2, Amelie Forget1,2, Lucie Blais3,4.   

Abstract

Objectives To compare the prevalence of major malformations using different case ascertainment definitions and to evaluate their impact on maternal asthma-major malformations association. Methods A cohort of pregnancies with and without asthma between 1990 and 2010 was formed. We used two classification methods: the Two step Congenital Malformation Classification (TCMC) and the Canadian Congenital Anomalies Surveillance System (CCASS). Within each method, three case definitions were compared: (1) ≥1 diagnosis in the hospital database; (2) ≥1 diagnosis in the hospital database or ≥2 in the medical claims; and (3) ≥1 diagnosis in the hospital database or ≥1 in the medical claims. We calculated the prevalence of major malformations and adjusted odds ratios (aORs) for maternal asthma association. Results Of 467,946 pregnancies, 12.3 % were with active asthma. The prevalence estimates were: TCMC 5.10-7.08 % and CCASS 7.03-10.57 %. Asthma-major malformations association was weaker with the CCASS (aOR 1.14-1.20) versus TCMC (aOR 1.22-1.26). Discussion The case ascertainment definitions with ≥1 hospitalization are likely to be the most reliable in similar administrative databases. The case ascertainment definition had a considerable impact on the prevalence of major malformations, but hardly influenced the aORs. Future studies should formally assess the validity of the case ascertainment definitions and allow generalizability to other maternal exposures.

Entities:  

Keywords:  Administrative databases; Asthma; Case definitions; Congenital malformations; Pregnancy

Mesh:

Substances:

Year:  2017        PMID: 27443652     DOI: 10.1007/s10995-016-2147-1

Source DB:  PubMed          Journal:  Matern Child Health J        ISSN: 1092-7875


  27 in total

1.  Congenital heart defect case ascertainment by the Alberta Congenital Anomalies Surveillance System.

Authors:  Tanya Bedard; R Brian Lowry; Barbara Sibbald; Joyce R Harder; Cynthia Trevenen; Vera Horobec; John D Dyck
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-04-04

2.  Models for longitudinal data: a generalized estimating equation approach.

Authors:  S L Zeger; K Y Liang; P S Albert
Journal:  Biometrics       Date:  1988-12       Impact factor: 2.571

3.  First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Authors:  Anick Bérard; Elodie Ramos; Evelyne Rey; Lucie Blais; Martin St-André; Driss Oraichi
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-02

4.  Congenital malformations: agreement between diagnostic codes in an administrative database and mothers' reports.

Authors:  Sophie Kulaga; Anick Bérard
Journal:  J Obstet Gynaecol Can       Date:  2010-06

5.  Urban versus rural residence and occurrence of septal heart defects in Texas.

Authors:  Peter H Langlois; Angela Scheuerle; Scott A Horel; Susan E Carozza
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2009-09

6.  Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.

Authors:  Lucie Blais; Amélie Forget
Journal:  J Allergy Clin Immunol       Date:  2008-04-14       Impact factor: 10.793

7.  Association between maternal chronic conditions and congenital heart defects: a population-based cohort study.

Authors:  Shiliang Liu; K S Joseph; Sarka Lisonkova; Jocelyn Rouleau; Michiel Van den Hof; Reg Sauve; Michael S Kramer
Journal:  Circulation       Date:  2013-06-28       Impact factor: 29.690

8.  Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study.

Authors:  J Yang; S L Carmichael; M Canfield; J Song; G M Shaw
Journal:  Am J Epidemiol       Date:  2007-10-17       Impact factor: 4.897

9.  High doses of inhaled corticosteroids during the first trimester of pregnancy and congenital malformations.

Authors:  Lucie Blais; Marie-France Beauchesne; Catherine Lemière; Naoual Elftouh
Journal:  J Allergy Clin Immunol       Date:  2009-12       Impact factor: 10.793

10.  Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.

Authors:  Sherif Eltonsy; Amelie Forget; Marie-France Beauchesne; Lucie Blais
Journal:  J Allergy Clin Immunol       Date:  2014-09-13       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.